Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have a confirmed diagnosis of hepatocellular carcinoma (a type of primary liver cancer), diagnosed according to specific Chinese clinical guidelines
- People whose liver cancer has been assessed as suitable for surgery — either removal of part of the liver or a liver transplant — and falls within certain early-to-intermediate stages (stages Ia, Ib, or IIa) as defined by Chinese cancer guidelines
- People who have had imaging scans (such as CT or MRI) completed within one month before their surgery
- People who have had a tissue sample examined under a microscope, with results that include information about whether tiny blood vessel involvement (called microvascular invasion) was present or not
Who may not be able to join:
- People who have already received any treatment for their liver cancer before surgery, including procedures such as chemotherapy delivered directly to the liver (TACE), heat-based tumour destruction (radiofrequency ablation), any systemic drug therapy, or any other pre-surgical cancer treatment
- People whose cancer has spread into major blood vessels, bile ducts, or lymph nodes, or has spread to areas outside the liver
- People whose liver cancer is spread widely throughout the liver, or where the tumour has burst and caused bleeding
- People for whom key data needed for the main study analysis is missing or unavailable
- People whose medical imaging is of too low a quality to allow accurate analysis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13811833760
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Area Under the Receiver Operating Characteristic Curve (AUC); Accuracy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.